NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Collections About News Help Login
Back to Results
Bisphosphonates as a Countermeasure to Space Flight Induced Bone LossBisphosphonates as a Countermeasure to Space Flight Induced Bone Loss (Bisphosphonates) will determine whether antiresorptive agents, in conjunction with the routine inflight exercise program, will protect ISS crewmembers from the regional decreases in bone mineral density documented on previous ISS missions.
Document ID
20090014795
Acquisition Source
Johnson Space Center
Document Type
Other
Authors
LeBlanc, Adrian (Universities Space Research Association Houston, TX, United States)
Matsumoto, Toshio (Tokushima Univ. Kuramoto, Japan)
Jones, Jeffrey A. (NASA Johnson Space Center Houston, TX, United States)
Shapiro, Jay (Johns Hopkins Univ. Baltimore, MD, United States)
Lang, Thomas F. (California Univ. San Francisco, CA, United States)
Smith, Scott M. (NASA Johnson Space Center Houston, TX, United States)
Shackelford, Linda C. (NASA Johnson Space Center Houston, TX, United States)
Sibonga, Jean (Universities Space Research Association Houston, TX, United States)
Evans, Harlan (Wyle Labs., Inc. Houston, TX, United States)
Spector, Elisabeth (Wyle Labs., Inc. Houston, TX, United States)
Koslovskaya, Inessa (Academy of Sciences (Russia) Moscow, Russian Federation)
Date Acquired
August 24, 2013
Publication Date
January 1, 2009
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-17962-8
Distribution Limits
Public
Copyright
Public Use Permitted.

Related Records

There are no records associated with this record.
No Preview Available